Vous avez cherché: cad (Anglais - Maltais)

saray cad.
saray cad. no.

coronary artery disease (cad)
mard tal-arterji koronarji (cad)

european commission delegation uğur mumcu cad. no 88 gaziosmanpaşa tr-ankara tel.
delegazzjoni talkummissjoni ewropea uğur mumcu cad. no 88 gaziosmanpaşa tr-ankara tel. (90-312) 459 87 00e-mail: delegation-turkey@ec.europa.eu

randomised controlled data found no increased risk of cad in hysterectomised women using oestrogen-only therapy.
id-dejta kkontrollata b’mod aleatorju ma sabet l-ebda riskju miżjud ta’ cad f’nisa li kellhom isterektomija li użaw terapija ta’ estroġeni biss.

there is no evidence from randomised controlled trials of protection against myocardial infarction in women with or without existing cad who received oestrogen-only therapy.
ma hemm l-ebda evidenza mill-provi kliniċi kkontrollati aleatorji ta’ protezzjoni kontra l-infart mijokardijaku f’nisa b’cad eżistenti jew mingħajr, li jirċievu terapija ta’ estroġeni biss.

19 in a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (cad) (> 70% stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7% and 6% respectively compared to baseline.
fi studju ta ’ l- effetti imodinamiċi ta ’ doża waħda orali ta ’ 100 mg sildenafil f’ 14- il pazjenti b’ mard sever ta ’ l- arterji tal- qalb (cad) (> 70% stenożi f’ ta mill- anqas arterja waħda tal- qalb), il- pressjoni medja tad- demm sistolika u dijastolika waqt is- serħan naqsu b’ 7% u 6% rispettivament mqabbla mal - linja bażi.